This study of nine PDE-ALDH7A1 patients and 9393 negative controls supports 2-OPP as a reliable and high-performing primary biomarker for the biochemical screening of pyridoxine-dependent epilepsy due to ALDH7A1 deficiency. The gene discussed is ALDH7A1; the disease is pyridoxine-dependent epilepsy.